Why did PHRX.CN stock fall sharply today?

PHRX.CN stock fell due to thin trading volume and negative sentiment. Low liquidity amplified selling after an open at **C$0.02**, pushing the close to **C$0.01** with **28,921.00** shares changing hands.

What are the main financial risks for Pharmadrug (PHRX.CN)?

Key risks include negative EPS of **-0.01**, a current ratio near **0.01**, and negative book value per share. These metrics point to cash strain and high execution risk for PHRX.CN stock.

Does Meyka AI provide a price forecast for PHRX.CN stock?

Yes. Meyka AI's forecast model projects a monthly price of **C$0.01** for PHRX.CN stock, implying **0.00%** near-term upside versus the current price. Forecasts are model-based and not guarantees.

What catalysts should investors watch for PHRX.CN stock?

Watch the May earnings announcement, clinical trial updates, and research partnerships with Johns Hopkins and University of Michigan. Positive trial news could change sentiment for PHRX.CN stock.

CA Stocks

PHRX.CN Pharmadrug CNQ down 33.33% to C$0.01 on 17 Feb 2026: liquidity risks

ByDanny Kontos February 17, 2026

PHRX.CN stock plunged -33.33% to C$0.01 on 17 Feb 2026 during market hours on the CNQ in Canada. The drop follows a one-day move from an open of C$0.02 to a low of C$0.01, with 28,921.00 shares traded. Intraday volume remained below the 50-day average, flagging limited liquidity and higher volatility. Investors should watch cash runway, research partnerships and short-term catalysts before considering positions in Pharmadrug Inc.